Defining value across the healthcare spectrum…


Many Biotech and Life Sciences firms lack the expertise to integrate health economics and outcomes research (HEOR) into commercialization plans.


Over 750 Life Science companies are hiring in HEOR space today – yet, it’s rare to see a lab or IVD manufacturer1

791 companies exhibited at the 2018 American Association for Clinical Chemistry (AACC) meeting2

Over 275,000 registered clinical trial studies currently ongoing in the United States3

DxEcon would welcome the opportunity to work as part of your extended team to define value and connect market access dots across stakeholders.


SIEs (Self insured employers) & those with innovative carve out programs



Health insurance organizations, TPA’s and health systems



Benefit Consultants, Captive Insurance Advisors, Insurance Brokers, Business Groups, Consortiums, State Associations